沃森生物(300142.SZ):工投集團轉讓1.98%股份 第一大股東變更為劉俊輝
格隆匯2月14日丨沃森生物(300142.SZ)公佈,2020年2月14日,公司收到公司持股5%以上股東雲南省工業投資控股集團有限責任公司(以下簡稱“工投集團”)發來的《雲南省工業投資控股集團有限責任公司關於大宗交易轉讓沃森生物股份的告知函》。工投集團於2020年2月14日通過深圳證券交易所證券交易系統以大宗交易方式轉讓了其所持有的公司股票3044.12萬股,轉讓數量佔公司股份總數的1.98%。
本次股份轉讓前,工投集團持有公司股份1.07億股,佔公司股份總數的6.99%,為公司第一大股東,本次股份轉讓後,工投集團持有公司股份7694.95萬股,佔公司股份總數的5.01%。
截至本公告披露日,公司股東劉俊輝持有公司股份8689.785萬股,佔公司股份總數的5.65%,劉俊輝的夫人黃靜持有公司股份358.85萬股,佔公司股份總數的0.23%,與劉俊輝為一致行動人,劉俊輝成為公司第一大股東。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.